Disparities in cancer outcomes: lessons learned from children with cancer

Pediatr Blood Cancer. 2011 Jun;56(6):994-1002. doi: 10.1002/pbc.23078. Epub 2011 Feb 15.

Abstract

Disparities in cancer burden by race/ethnicity have been reported, primarily in adults with cancer. However, there appear to be gaps in the pediatric oncology literature with regards to a comprehensive overview on this topic. Extant literature is used to highlight the results of studies focusing on racial and ethnic disparities in outcome observed in selected childhood cancers. A comprehensive approach is utilized to understand possible underlying causes of disparities in cancer outcomes, and to highlight the gaps that currently exist. This review helps define areas of future research that could help develop targeted, disease-specific approaches to eliminate the disparities.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • African Americans / statistics & numerical data
  • Antineoplastic Agents / adverse effects
  • Asian Americans / statistics & numerical data
  • Child
  • Disease-Free Survival
  • European Continental Ancestry Group / statistics & numerical data
  • Health Services Accessibility
  • Hispanic Americans / statistics & numerical data
  • Hodgkin Disease / ethnology
  • Hodgkin Disease / mortality
  • Hodgkin Disease / therapy
  • Humans
  • Leukemia, Myeloid, Acute / ethnology
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / therapy
  • Neoplasms / ethnology*
  • Neoplasms / mortality
  • Neoplasms / therapy
  • Neuroblastoma / ethnology
  • Neuroblastoma / mortality
  • Neuroblastoma / therapy
  • Pharmacogenetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / ethnology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Rhabdomyosarcoma / ethnology
  • Rhabdomyosarcoma / mortality
  • Rhabdomyosarcoma / therapy
  • SEER Program
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents